Verdad Advisers’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Verdad Advisers's SGP Position: Q3 2026 in Review
Verdad Advisers opened a new position in SpyGlass Pharma (SGP) in Q3 2026: 56,708 shares worth $1.47M. The stake represents 1.58% of the portfolio and ranks #8 among its holdings.
70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Verdad Advisers held 56,708 shares of SpyGlass Pharma worth $1.47M as of Q3 2026.
- SpyGlass Pharma was a new Verdad Advisers position in Q3 2026.
- SpyGlass Pharma made up 1.58% of Verdad Advisers's portfolio in Q3 2026, its #8 holding.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.